Sign in
Create a Profile
Endometrial Effects of Metformin Action in Women With Polycystic Ovarian Syndrome (PCOS)
Diseases and Conditions Researched
Polycystic Ovarian Syndrome
What is the purpose of this trial?
The investigators aim is to conduct a prospective un-blinded pilot study of premenopausal women diagnosed with Polycystic Ovarian Syndrome (PCOS), defined using criteria developed at the 1990 NICHD conference on PCOS, undergoing treatment for ovulation induction with Metformin. We propose that improving insulin sensitivity with use of Metformin in women diagnosed with PCOS has facilitatory influences on the uterine endometrium.
Participation Guidelines
Gender: Female
Click here for detailed participation information for this trial.
| Sponsors: | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Yale University |
|---|---|
| Dates: | February 16, 2010 |
| Last Updated: | February 21, 2012 |
| Study HIC#: | 0905005203 |
| Clinicaltrials.gov ID: | NCT01070160 |
How will my information be used?
For more information about this trial, contact:
Joanne Williams
203-785-3463
joanne.williams@yale.edu
Principal Investigator
Lubna Pal, MBBS MRCOG MSc
Obstetrics, Gynecology & Reproductive Sciences
Beth Rackow, MD
Hugh Taylor, MD
Pinar Kodaman, MD/PhD
Obstetrics, Gynecology & Reproductive Sciences
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
